Regulatory CD8+CD122+ T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells

Metabolic Brain Disease

Volumn 30, Issue 4, 2015, Pages 911-924

  Bodhankar, Sheetal ^a,b   Chen, Yingxin ^b   Lapato, Andrew ^a,b   Vandenbark, Arthur A ^a,b   Murphy, Stephanie J ^b   Saugstad, Julie A ^b   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

IL 10 secreting B cells; IL 10+CD8+CD122+ regulatory T cells; Inflammatory cells; MCAO

Indexed keywords

CD11B ANTIGEN; CD1D ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; COMPLEMENTARY DNA; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GREEN FLUORESCENT PROTEIN; ICAM1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL10 PROTEIN, MOUSE; IL2RB PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; BRAIN INFARCTION SIZE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL STROKE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOREGULATION; INFLAMMATORY CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; MORTALITY; MOUSE; NEUROPROTECTION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); STROKE; TRANSPLANTATION; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; STROKE; TREATMENT OUTCOME;

EID: 84942943769     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9639-8     Document Type: Article

References (39)

1. Becker K, Kindrick D, Relton J, Harlan J, Winn R (2001) Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32: 206-11.
2. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H (2013) IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 28: 375-86.
3. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H (2014) Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wildtype B-cell-sufficient mice. Metab Brain Dis 29: 59-73.
4. Campanella M, Sciorati C, Tarozzo G, Beltramo M (2002) Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33: 586-92.
5. Chen Y, Bodhankar S, Murphy SJ, Vandenbark AA, Alkayed NJ, Offner H (2012) Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis 27: 487-93.
6. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238: 53-6.
7. Clarkson BD, Ling C, Shi Y, Harris MG, Rayasam A et al (2014) T cellderived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med 211: 595-604.
8. Endharti AT, Rifa IM, Shi Z, Fukuoka Y, Nakahara Yet al (2005) Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175: 7093-7.
9. Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S et al (2011) CD8+ CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis. J Immunol 186: 41-52.
10. Fang MC, Cutler DM, Rosen AB (2010) Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med 5: 406-9.
11. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C et al (2000) Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12: 2265-72.
12. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808.
13. Jin R, Liu L, Zhang S, Nanda A, LiG (2013) Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res 6: 834-51.
14. Kim JS, Yoon SS, Kim YH, Ryu JS (1996) Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27: 1553-7.
15. Lee YH, Ishida Y, Rifa'i M, Shi Z, Isobe K, Suzuki H (2008) Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 180: 825-32.
16. Li P, Gan Y, Sun BL, Zhang F, Lu B et al (2013) Adoptive regulatory Tcell therapy protects against cerebral ischemia. Ann Neurol 74: 458-71.
17. Liesz A, ZhouW, Mracsko E, Karcher S, Bauer H et al (2011) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134: 704-20.
18. Liesz A, ZhouW, Na SY, Hammerling GJ, Garbi N et al (2013) Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci 33: 17350-62.
19. Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S et al (2009) Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 183: 2312-20.
20. Mangalam AK, Luckey D, Giri S, Smart M, Pease LR et al (2012) Two discreet subsets of CD8 T cells modulate PLP (91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. J Autoimmun 38: 344-53.
21. Minino AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59: 1-126.
22. Offner H, Hurn PD (2012) A novel hypothesis: regulatory B lymphocytes shape outcome fromexperimental stroke. Transl Stroke Res 3: 324-30.
23. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006a) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood FlowMetab 26: 654-65.
24. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME et al (2006b) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176: 6523-31.
25. Okuno Y, Murakoshi A, NegitaM, Akane K, Kojima S, Suzuki H (2013) CD8+ CD122+ regulatory T cells contain clonally expanded cells with identical CDR3 sequences of the T-cell receptor beta-chain. Immunology 139: 309-17.
26. Ooboshi H, Ibayashi S, Shichita T, Kumai Y, Takada J et al (2005) Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111: 913-9.
27. Pelidou SH, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H (1999) High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 6: 437-42.
28. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS et al (2011) Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 31: 8556-63.
29. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H (2004) Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200: 1123-34.
30. Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16: 360-6.
31. Sattler S, Ling GS, Xu D, Hussaarts L, Romaine A et al (2014) IL-10-producing regulatory B cells induced by IL-33 (Breg (IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J Autoimmun 50: 107-22.
32. Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251: 189-92.
33. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW et al (2001) Interleukin-10 in the brain. Crit Rev Immunol 21: 427-49.
34. Subramanian S, Yates M, Vandenbark AA, Offner H (2011) Oestrogenmediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory Tcells implicates compensatory pathways including regulatory B cells. Immunology 132: 340-7.
35. Suzuki H, Shi Z, Okuno Y, Isobe K (2008) Are CD8+CD122+ cells regulatory T cells or memory T cells? Hum Immunol 69: 751-4.
36. Van Exel E, Gussekloo J, de Craen AJ, Bootsma-van derWiel A, Frolich M, Westendorp RG (2002) Inflammation and stroke: the Leiden 85-plus study. Stroke 33: 1135-8.
37. Yanaba K, Bouaziz JD, Haas KM, Poe JC, FujimotoM, Tedder TF (2008)A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-50.
38. Zhang B, Subramanian S, Dziennis S, Jia J, Uchida M et al (2010) Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol 184: 4087-94.
39. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B et al (2013) Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol 23: 34-44.